CORRECTION: Cerence Q3 2024 Adj. EPS $0.19 Beats $0.05 Estimate, Sales $70.530M Beat $68.469M Estimate
Portfolio Pulse from Benzinga Newsdesk
Cerence reported its Q3 2024 adjusted EPS of $0.19, beating the estimate of $0.05. Sales were $70.530 million, surpassing the expected $68.469 million.
August 08, 2024 | 11:08 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cerence's Q3 2024 adjusted EPS of $0.19 significantly beat the estimate of $0.05, and sales of $70.530 million also surpassed the expected $68.469 million.
The significant beat in both EPS and sales indicates strong financial performance, likely leading to a positive short-term impact on CRNC's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100